Artigo Original
Bittencourt et al.
Células endoteliais, micropartículas e corredores
Arq Bras Cardiol. 2017; 108(3):212-216
1. Chan KH, Simpson PJ, Yong AS,Dunn LL, Chawantanpipat C, Hsu C, et al. The
relationshipbetweenendothelialprogenitorcellpopulationsandepicardialand
microvascular coronary disease-a cellular, angiographic and physiologic study.
PLoSOne. 2014;9(4):e93980.
2. Madonna R, De Caterina R. Circulating endothelial progenitor cells: Do they
live up to their name? Vascul Pharmacol. 2015 Apr-Jun.67-69:2-5.
3. Saad MI, Abdelkhalek TM, Saleh MM, Kamel MA, Youssef M, Tawfik SH, et
al.. Insights into the molecular mechanisms of diabetes-induced endothelial
dysfunction: focus on oxidative stress and endothelial progenitor cells.
Endocrine. 2015;50(3):537-67.
4. Peng J, Liu B, Ma QL, Luo XJ. Dysfunctional endothelial progenitor cells in
cardiovascular diseases: role of NADPH oxidase. J Cardiovasc Pharmacol.
2015;65(1):80-7.
5. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating
endothelial progenitor cells and cardiovascular outcomes. N Engl J Med.
2005;353(10):999-1007.
6. Bakogiannis C, Tousoulis D, Androulakis E, Briasoulis A, Papageorgiou
N, Vogiatzi G,et al. Circulating endothelial progenitor cells as
biomarkers for prediction of cardiovascular outcomes. Curr Med Chem.
2012;19:2597-604.
7. Mause SF, Weber C. Microparticles: protagonists of a novel
communication network for intercellular information exchange. Circ
Res. 2010;107(9):1047-57.
8. Berezin A, Zulli A, Kerrigan S, Petrovic D, Kruzliak P. Predictive role
of circulating endothelial-derived microparticles in cardiovascular
diseases. Clin Biochem. 2015;48(9):562-8.
9. Nomura S, Shimizu M. Clinical Significance of procoagulant
microparticles. J Intensive Care. 2015;3(1):2.
10. Guiraud T, Gayda M, Juneau M, Bosquet L, Meyer P, Théberge-Julien G,
et al. A single bout of high-intensity interval exercise does not increase
endothelial or platelet microparticles in stable, physically fit men with
coronary heart disease. Can J Cardiol. 2013;29(10):1285-91.
11. Wahl P, Jansen F, Achtzehn S, Schmitz T, Bloch W, Mester J, et
al. Effects of high intensity training and high volume training on
endothelial microparticles and angiogenic growth factors. PLos One.
2014;9(4):e96024.
12. Camargo LM, França CN, Izar MC, Bianco HT, Lins LS, Barbosa SP,
et al. Effects of simvastatin/ezetimibe on microparticles, endothelial
progenitor cells and platelet aggregation in subjects with coronary heart
disease under platelet therapy. Braz J Med Biol Res. 2014;47(5):432-7.
13. Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, et al.
Effects of ezetimibe on endothelial progenitor cells and microparticles
in high-risk patients. Cell Biochem Biophys. 2014;70(1):687-96.
14. Pinheiro LF, França CN, Izar MC, Barbosa SP, Bianco HT, Kasmas SH,et
al. Pharmacokinetic interactions between clopidogrel and rosuvastatin:
effects on vascular protection in subjects with coronary heart disease.
Int J Cardiol. 2012;158(1):1125-9.
15. da Silva EF, Fonseca FA, França CN, Ferreira PR, Izar MC, Salomão R,et al.
Imbalance between endothelial progenitor cells and microparticles in HIV-
infectedpatientsnaiveforantirretroviraltherapy.AIDS.2011;25(13):1595-601.
16. Pirro M, Schillaci G, Menecali C, Bagaglia F, Paltriccia R, Vaudo G, et
al. Reduced number of circulating endothelial progenitors and HOXA9
expression in CD34+ cells of hypertensive patients. J Hypertens.
2007;25(10):2093-9.
17. Lamirault G, Susen S, Forest V, Hemont C, Parini A, Le Corvoisier P, et al.
Difference in mobilization of progenitor cells after myocardial infarction
in smoking versus non-smoking patients: insights from the BONAMI trial.
Stem Cell Res Ther. 2013;4(6):152.
18. Rodríguez C, Slevin M, Rodríguez-Calvo R, Kumar S, Krupinski J, Tejerina
T, et al. Modulation of endothelium and endothelial progenitor cell
function by low-density lipoproteins: implication for vascular repair,
angiogenesis and vasculogenesis. Pathobiology. 2009;76(1):11-22.
19. Goligorsky MS. Endothelial progenitor cells: from senescence to
rejuvenation. Semin Nephrol. 2014;34(4):365-73.
20. Koutroumpi M, Dimopoulos S, Psarra K, Kyprianou T, Nanas S.
Circulating endothelial and progenitor cells: Evidence from acute and
long-term exercise effects. World J Cardiol. 2012;4(12):312-26.
21. De Biase C, De Rosa R, Luciano R, De Luca S, Capuano E, Trimarco B,et
al. Effects of physical activity on endothelial progenitor cells (EPCs). Front
Physiol. 2014; Feb 3;4:414.
22. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jürgens K, et
al. Physical training increases endothelial progenitor cells, inhibits
neointima formation, and enhances angiogenesis. Circulation.
2004;109(2):220-6.
23. Hoetzer GL, Van Guilder GP, Irmiger HM, Keith RS, Stauffer BL,
DeSouza CA. Aging, exercise, and endothelial progenitor cell
clonogenic and migratory capacity in men. J Appl Physiol. 1985; (1985).
2007;102(3):847-52.
24. Lee SK, Yang SH, Kwon I, Lee OH, Heo JH. Role of tumour necrosis
fator receptor-1 and nuclear fator-kB in productionof TNF-
α
-induced
pro-inflammatory microparticles in endothelial cells. Thromb Haemost.
2014;112(3):580-8.
25. Enjeti AK, Lincz LF, Seldon M. Microparticles in health and disease.
Semin Thromb Hemost. 2008;34(7):683-91.
26. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A.
Cell-derived microparticles circulate in healthy humans and support low
grade thrombin generation. Thromb Haemost. 2001;85(4):639-46.
27. Nomura S. Function and clinical significance of platelet-derived
microparticles. Int J Hematol. 2001;74(4):397-404.
28. Keuren FJ, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers
J. Effects of storage-induced platelet microparticles on the initiation
and propagation phase of blood coagulation. Br J Haematol.
2006;134(3):307-13.
29. Lannan KL, Sahler J, Kim N, Spinelli SL, Maggirwar SB, Garraud O, et al.
Breaking the mold: transcription factors in the anucleate platelet and
platelet-derived microparticles. Front Immunol. 2015;Feb 6:48.
30. Fernandes JM,Rosado-AlvaresD,DaSilvaGrigolettoME,Rangel-ZunigaOA,
Landaeta-DiazLL,etal.Moderate-to-high-intensitytrainingandahypocaloric
Mediterraneandietenhanceendotelialprogenitorcellsandfitness insubjects
with the metabolic syndrome. Clin Sci (Lond). 2012 ; 123(6):361-73.
31. Rakobowchuk M, Harris E, Taylor A, Baliga V, Cubbon RM, Rossiter HB,
et al. Heavy and moderate interval exercise training alters low-flow-
mediated constriction but does not increase circulation progenitor cells
in healthy humans. Exp Physiol. 2013;97(3):375-85.
32. Kruger K, Alack K, Ringseis R, Mink L, Pfeifer E, Schinle M, et al. Apoptois
of T-Cell subsets after acute high-intensity interval exercise. Med Sci
Sports Exerc. 2016;48(10):2021-9.
33. Adams V, Linke A, Breuckmann F, Leineweber K, Erbs S, Kränkel N, et
al. Circulating progenitor cells decrease immediately after marathon
race in advanced-age marathon runners. Eur J Cardiovasc Prev Rehabil.
2008;15(5):602-7.
Referências
216
